(Q40673931)

22 September 2017

Smad expression of hepatic stellate cells in liver cirrhosis in vivo and hepatic stellate cell line in vitro (English)

1 reference

22 September 2017

0 references

Yukisato Kitamura

1

1 reference

PubMed ID

12558865

22 September 2017

Haruaki Ninomiya

series ordinal

2

1 reference

22 September 2017

1 January 2003

1 reference

22 September 2017

Pathology International

1 reference

22 September 2017

53

1 reference

22 September 2017

1

1 reference

22 September 2017

18-26

1 reference

TGF-beta receptor signaling

22 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Glial fibrillary acidic protein--a cell type specific marker for Ito cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2003.01431.X

10.1046/J.1440-1827.2003.01431.X

21 January 2018

Identifiers

DOI

1 reference

release_54hehgt6ljgkdg62wqpiktjsd4

22 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/54hehgt6ljgkdg62wqpiktjsd4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12558865

1 reference

PubMed ID

12558865